| Product Code: ETC7178029 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to heavily rely on imports of insulin biosimilars, with top exporters being New Zealand, USA, Australia, India, and Taiwan, Province of China. The market concentration, as measured by the HHI, remained at a very high level. The compound annual growth rate (CAGR) for the period 2020-2024 was notably negative at -57.08%, with a consistent decline in growth rate from 2023 to 2024 at -57.1%. These trends suggest a challenging market environment for insulin biosimilars in Fiji, with potential implications for future import dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Insulin Biosimilars Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Insulin Biosimilars Market - Industry Life Cycle |
3.4 Fiji Insulin Biosimilars Market - Porter's Five Forces |
3.5 Fiji Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Fiji Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F |
3.7 Fiji Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Fiji Insulin Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Insulin Biosimilars Market Trends |
6 Fiji Insulin Biosimilars Market, By Types |
6.1 Fiji Insulin Biosimilars Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Fiji Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F |
6.1.4 Fiji Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F |
6.1.5 Fiji Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F |
6.2 Fiji Insulin Biosimilars Market, By Indicative |
6.2.1 Overview and Analysis |
6.2.2 Fiji Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.2.3 Fiji Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.3 Fiji Insulin Biosimilars Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Fiji Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Fiji Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Fiji Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Insulin Biosimilars Market Import-Export Trade Statistics |
7.1 Fiji Insulin Biosimilars Market Export to Major Countries |
7.2 Fiji Insulin Biosimilars Market Imports from Major Countries |
8 Fiji Insulin Biosimilars Market Key Performance Indicators |
9 Fiji Insulin Biosimilars Market - Opportunity Assessment |
9.1 Fiji Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Fiji Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F |
9.3 Fiji Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Fiji Insulin Biosimilars Market - Competitive Landscape |
10.1 Fiji Insulin Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Fiji Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |